Skip to content
Conference

AI-based Clinical Decision Support for Heart Disease Prediction

Jul 2026 · 2026 International Conference on Intelligent and Sustainable AI Systems (ICOSAAS) · pp. 1487-1492 · 0 citations · 19 references

Abstract

Cardiovascular disease is the leading cause of death worldwide, and early, data-driven risk identification can support timely clinical intervention. This paper presents a study of deep learning models for binary heart disease prediction on a large structured clinical dataset of 50,000 records described by 20 demographic, lifestyle, medical-history, and physiological attributes. After a preprocessing pipeline that recovers a mislabelled "no-alcohol" category, one-hot encodes categorical variables, and standardizes numerical features, we design and compare three deep neural architectures, a regularized deep neural network (DNN), a bidirectional long short-term memory network (BiLSTM), and a hybrid CNN–BiLSTM, against a logistic-regression baseline. All models are evaluated on a held-out test set using accuracy, precision, recall, F1-score, and the area under the ROC curve. The proposed DNN achieves the highest performance, with 99.68% accuracy, a 99.65% F1-score, and an ROC area of approximately 1.0, misclassifying only 24 of 7,500 test samples and outperforming the BiLSTM (98.95%), the CNN–BiLSTM (98.15%), and the linear baseline (92.11%). A feature-correlation and ablation analysis shows that the outcome is governed by a small set of non-linearly interacting risk factors, hypertension, age, total cholesterol, diabetes, and prior myocardial infarction, which explains why the deep models capture a decision boundary that the linear model cannot. Because the dataset is a synthetic benchmark, the results are reported transparently, and the need for external validation on real-world clinical cohorts is discussed.

View source

Similar papers

Sep 2026

Ensemble and Explainable AI-Based Framework for Early Prediction of Heart Disease

At present, heart disease is one of the major causes of death all over the world. Identification of cardiovascular risk at the initial stage will help improve the outcomes of the affected patients and provide adequate care, thereby lessening the economic burden on the community's health. This work aims to present a...

Sudipta Bhattacharya, Bingshati Mondal, Nabanita Das et al. · 0 citations
Open access 2026

Comparative performance of machine learning and deep learning models for heart disease prediction in a small clinical dataset.

BACKGROUND Machine learning (ML) and deep learning (DL) models are increasingly applied to cardiovascular risk prediction, yet their comparative performance in small tabular clinical datasets remains uncertain. This study compared conventional machine learning models and a deep neural network for predicting angiographi...

Erfan Barootchi, Pardis Zamani, R. Birgani et al. · 0 citations
Conference

A Comparative Analysis of Machine Learning Models for Heart Disease Prediction Using Clinical Parameters

Cardiovascular disease remains one of the leading causes of mortality worldwide, with early detection being crucial for improving patient outcomes. This study aims to develop and validate a machine learning-based prediction model for heart disease using electronic health records from a major hospital system in New Jers...

O. Osama, Daehan Won, M. Khasawneh et al. · 0 citations
Open access Sep 2026

A Comparative Study of Machine Learning Algorithms for Detecting Heart Disease

Cardiovascular diseases remain a leading cause of mortality worldwide. Identifying underlying clinical phenotypes early, such as distinct categories of chest pain, is vital for diagnostic triage and downstream medical decision-making. This study evaluates the performance of four prominent machine learning algorithms –...

Twana Abdulqader Mohammed, S. Salh · 0 citations

Development of a machine learning model for diabetes risk prediction

Diabetes mellitus imposes a growing burden on health systems, yet the prediagnostic period, when prevention is still possible, is poorly characterized by existing prediction tools. This independent study develops and evaluates an endto-end longitudinal diabetes-risk modeling pipeline using twelve years of annual healt...

Pitikorn Khlaisamniang · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.